EDAP TMS is the world leader in therapeutic ultrasound
Having been present in the market for more than 25 years, EDAP TMS (NASDAQ : EDAP) develops minimally-invasive therapeutic solutions for urology.
By consistently investing in Research & Development (R&D) and by forming partnerships with internationally-renowned medical research institutions, EDAP TMS has been able to patent innovative technologies.
EDAP TMS is present in many countries through an extensive network of subsidiaries and distribution partners. The company focuses on producing a high standard of service for health care practitioners: mobile equipment, training centers, maintenance network.
General news
Ablatherm HIFU receives approval in Argentina EDAP TMS just obtained approval from the Minitry of Health in Argentina for Ablatherm HIFU for the minimally-invasive treatment of localized prostate cancer. After being approved in Brazil earlier this year, the approval in Argentina shows that Ablatherm HIFU is gaining acceptance in South America.
AURO publishes official guidelines regarding HIFU treatment In its latest recommendations, the AURO (Association of Italian Urologists) recommends Ablatherm® HIFU treatment as first-line treatment for localized prostate cancer. This publication coming a year after the publication of similar recommendations by the AFU (French Association of Urology) reinforces the growing place of HIFU in the treatment of prostate cancer.
Ablatherm® HIFU confirms success in South Africa
With 3 new treatment centers in Pretoria, Johannesburg and Durban, Ablatherm confirms its presence in South Africa. The country now counts 4 Ablatherm® HIFU treatment centers in major cities of the country.
Visit www.hifu-planet.com website to view the full list of Ablatherm® HIFU treatment centers.
EAU 2009 in Stockholm highlights HIFU 12.000 urologists attended this year's EAU congress in Stockholm which is a particularly successful edition for EDAP TMS. The EAU hosted the EDAP TMS sponsored HIFU symposium with 200 urologists attending from all over the world. Vincenzo Ficarra from University of Padua, Italy chaired the symposium around the theme of High Intensity Focused Ultrasound in the Modern Urology Practice.
Ablatherm® HIFU is now approved in Brazil Ablatherm® HIFU is now approved in Brazil adding new outlooks for the technology.
With the recent installation of Ablatherm® HIFU in Mexico, the expansion of HIFU is on its way in Latin America.
First Ablatherm® HIFU system is now treating in Mexico. The first Ablatherm® HIFU system was installed in Centro Médico Puerta de Hierro Hospital in Guadalajara this month and Dr. Jorge Gutierrez Aceves successfully performed the first treatments for localized prostate cancer. Mexico is the first country in Latin America to adopt Ablatherm® HIFU and the technology is now available in 26 countries worldwide.
3 Sonolith® i-sys systems are now in operation in Ecuador EDAP TMS installed 3 Sonolith® i-sys systems in Ecuador this January and the first treatments were performed successfully by the teams of highly trained physicans. The 3 Sonolith® i-sys are installed in Quito, the capital of Equator, Guayaquil, the largest city of the country and Cuenca, the capital of Azuay province. The national and local Equatorian media widely relayed the installation of these high-tech ESWL systems.
India treats its first prostate cancer patients with Ablatherm® HIFU
On January 21st, the first Indian patients from Muljibhai Patel Urological Hospital in Nadiad, successfully received Ablatherm® HIFU treatment. The Ablatherm® installed at MPUH is the first one installed in India and the technology is now available in more than 25 countries.
Ultrasound & Therapy Community website is launched EDAP TMS is proud to announce that launching of Ultrasound & Therapy Community website for Ablatherm® HIFU and Sonolith® users : "Continuous education and information network for EDAP TMS users". Designed to link Ablatherm® users via Internet, U&T Community website enables all users to have access to online training, videos, images and clinical publications all in one place.
Ablatherm® HIFU is now available in more than 200 centers. In September 2008, the 200th Ablatherm® HIFU treatment center started treating patients for localized prostate cancer.
2 new Ablatherm® HIFU treatment centers in the Netherlands. EDAP TMS is proud to announce the opening of 2 new Ablatherm® HIFU treatment centers in Zaandam and Roosendaal.
Ablatherm® is now operating in the Netherlands EDAP TMS is proud to announce that Ablatherm® is now available in a new country. Amphia Ziekenhuis in Breda (Netherlands) is the first hospital of the country equipped with Ablatherm®.
New HIFU planet website launched in Germany
EDAP TMS launched a dedicated patient website for German prostate cancer patients seeking information on prostate cancer treatment. Visit HIFU planet at http://www.hifu-planet.de/ . Patients will find all information on Ablatherm® treatment and treatment centers addresses.
HIFU planet website in Turkish EDAP TMS is proud to announce the launching of its patient website www.hifu-planet.com in Turkish. HIFU planet website is already available in English, French, German, Italian and Spanish and is dedicated to prostate cancer patients looking for information on Ablatherm® HIFU treatment. After only a few days of activity, 400 visits are recorded!
EDAP Highlights Minimally Invasive Robotic HIFU Technology At British Association of Urological Surgeons Annual Meeting Launches "@-REGISTRY" Database in the United Kingdom.
